Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNSNASDAQ:ESTANASDAQ:INGNNYSE:IVCNASDAQ:RTIX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$12.25+0.3%$12.46$11.75▼$25.36$564.64M1.14380,752 shs404,620 shsESTAEstablishment Labs$42.71+4.3%$35.64$26.56▼$52.41$1.18B0.74473,775 shs359,813 shsINGNInogen$7.03-0.7%$6.64$5.70▼$13.33$190.36M1.65242,660 shs130,979 shsIVCInvacare$0.50$0.33▼$2.53$20.01M0.38240,305 shs33,301 shsRTIXRTI Surgical$3.14$3.14$1.46▼$5.40$234.25M2.14622,541 shs686,036 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical+0.37%+1.32%-2.62%-14.75%-38.50%ESTAEstablishment Labs+4.35%+16.76%+23.30%+6.48%-6.01%INGNInogen-0.71%+5.40%+9.16%+1.15%-13.53%IVCInvacare0.00%0.00%0.00%0.00%0.00%RTIXRTI Surgical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAvanos Medical2.833 of 5 stars0.03.00.00.01.31.73.8ESTAEstablishment Labs1.3963 of 5 stars2.41.00.00.02.12.50.6INGNInogen4.255 of 5 stars3.34.00.03.91.41.71.3IVCInvacareN/AN/AN/AN/AN/AN/AN/AN/ARTIXRTI SurgicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 0.00N/AN/AN/AESTAEstablishment Labs 2.80Moderate Buy$52.4022.69% UpsideINGNInogen 2.50Moderate Buy$11.0056.47% UpsideIVCInvacare 0.00N/AN/AN/ARTIXRTI Surgical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AVNS, INGN, ESTA, RTIX, and IVC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/13/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$48.005/22/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Moderate Buy$12.005/16/2025ESTAEstablishment LabsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$62.005/14/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$48.005/8/2025INGNInogenStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $7.004/14/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold4/9/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$689.20M0.82$11.89 per share1.03$18.03 per share0.68ESTAEstablishment Labs$166.02M7.44N/AN/A$1.90 per share22.48INGNInogen$335.70M0.56N/AN/A$7.30 per share0.96IVCInvacare$872.46M0.00N/A0.77$5.54 per share0.00RTIXRTI Surgical$308.38M0.76$0.30 per share10.31$2.89 per share1.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$392.10M-$8.37N/A7.08N/A-55.80%6.26%4.63%7/30/2025 (Estimated)ESTAEstablishment Labs-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)INGNInogen-$35.89M-$1.15N/AN/AN/A-8.08%-14.76%-9.01%8/5/2025 (Estimated)IVCInvacare-$45.56M-$2.18N/AN/AN/A-9.99%-37.76%-7.18%N/ARTIXRTI Surgical-$211.64M-$0.16N/AN/AN/A-70.56%N/AN/AN/ALatest AVNS, INGN, ESTA, RTIX, and IVC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025ESTAEstablishment Labs-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million5/7/2025Q1 2025INGNInogen-$0.52-$0.25+$0.27-$0.25$79.57 million$82.28 million5/6/2025Q1 2025AVNSAvanos Medical$0.19$0.26+$0.07$0.14$161.75 million$167.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/AIVCInvacareN/AN/AN/AN/AN/ARTIXRTI SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.571.56ESTAEstablishment Labs5.723.362.05INGNInogenN/A3.072.67IVCInvacare4.821.320.78RTIXRTI SurgicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%ESTAEstablishment Labs72.91%INGNInogen89.94%IVCInvacare59.87%RTIXRTI Surgical60.97%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%ESTAEstablishment Labs11.44%INGNInogen1.46%IVCInvacare6.90%RTIXRTI Surgical3.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,22746.24 million45.02 millionOptionableESTAEstablishment Labs1,01828.92 million25.61 millionOptionableINGNInogen1,03026.89 million26.49 millionOptionableIVCInvacare3,00037.76 million35.15 millionOptionableRTIXRTI Surgical89174.60 millionN/AOptionableAVNS, INGN, ESTA, RTIX, and IVC HeadlinesRecent News About These CompaniesTyber Medical, Intech and Resolve Surgical Technologies combine to form a next-generation solutions provider to the Medical Device industryJanuary 14, 2025 | tmcnet.comRTI Surgical rebrands to EvergenDecember 17, 2024 | beckersspine.comBRTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative MedicineDecember 17, 2024 | markets.businessinsider.comRTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast ReconstructionNovember 25, 2024 | globenewswire.comACL Graft Market Research Report 2024-2029 with RTI Surgical, AlloSource, Arthrex, LifeNet Health, Bone Bank Allografts, MTF Biologics, Parametrics Medical, and JRF Ortho DominatingNovember 13, 2024 | globenewswire.comRTI Surgical Completes Acquisition of Collagen SolutionsNovember 1, 2024 | globenewswire.comRTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facilityOctober 30, 2024 | globenewswire.comRTI Surgical to acquire biologic companyOctober 7, 2024 | beckersspine.comBRTI Surgical Announces Agreement to Acquire Collagen SolutionsOctober 7, 2024 | globenewswire.comRTI Surgical appoints Chad Croasdale as Chief Commercial OfficerJuly 10, 2024 | globenewswire.comAlachua-based RTI Surgical completes purchase of Cook BiotechFebruary 2, 2024 | msn.comRTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast ReconstructionNovember 27, 2023 | benzinga.comNumber of students in Delhi govt schools decreases by over 30,000: RTIOctober 17, 2023 | deccanherald.comDRTI queries reveal several irregularities in MGNREGA scheme in West BengalOctober 8, 2023 | thehindu.comPM Modi didn’t take a single leave in last 9 years, attended over 3k events: RTISeptember 25, 2023 | businesstoday.inBPrepared Manuscript of Legislative Instrument on RTIAugust 5, 2023 | ghanaweb.comGThe Perioperative Surgical HomeJune 7, 2023 | medscape.comMTeaching Surgical Skills — Changes in the WindMay 24, 2023 | nejm.orgNPreventing Surgical Site InfectionsMay 23, 2023 | medscape.comM"A Surgical Strike Is The Answer"May 18, 2023 | outlookindia.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthBuybacks Galore: Repurchases From the Oval Office to Olive GardenBy Leo Miller | June 30, 2025View Buybacks Galore: Repurchases From the Oval Office to Olive GardenDarden Stock Set to Sizzle After Blowout Q4 and $1B BuybackBy Thomas Hughes | June 23, 2025View Darden Stock Set to Sizzle After Blowout Q4 and $1B BuybackAVNS, INGN, ESTA, RTIX, and IVC Company DescriptionsAvanos Medical NYSE:AVNS$12.25 +0.04 (+0.33%) As of 06/30/2025 03:58 PM EasternAvanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Establishment Labs NASDAQ:ESTA$42.71 +1.78 (+4.35%) As of 06/30/2025 04:00 PM EasternEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Inogen NASDAQ:INGN$7.03 -0.05 (-0.71%) As of 06/30/2025 04:00 PM EasternInogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Invacare NYSE:IVCInvacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.RTI Surgical NASDAQ:RTIXSurgalign Holdings, Inc. is a global medical technology company, which engages in designing, developing and manufacturing biologic metal and synthetic implants worldwide. It focuses on delivering spine solutions that drive clinical and economic outcomes. The company markets its products throughout the United States and other countries worldwide through an expanding network of independent distributors. The company was founded in February 1998 and is headquartered in Deerfield, IL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
